 NEW YORK, March 27, 2021 PRNewswire -- Juan Monteverde , founder and managing partner at Monteverde Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Research Alliance Corp. I RACA or the Company RACA relating to its proposed merger with POINT Biopharma, Inc. Under the terms of the agreement, RACA will acquire POINT through a reverse merger, with POINT emerging as a publicly traded company. The investigation focuses on whether Research Alliance Corp. I and its Board of Directors violated securities laws andor breached their fiduciary duties to the Company by 1 failing to conduct a fair process, 2 whether the transaction is properly valued, and 3 whether all material information has been disclosed. 